Between February and April 2026, High Tide's German based subsidiary Remexian sold 7.6 tonnes of medical cannabis in Germany, the highest amount it has ever sold in a single quarter. This was 21% more than the previous quarter, and 49% more than the same period a year earlier.
"Distributing 7.6 tonnes in a single quarter is not just a record for Remexian—it is clear evidence that our model is scaling in the largest medical cannabis market in Europe. What we are seeing now is the direct result of pairing a leading German distribution platform with High Tide's unparalleled procurement capabilities built over $2.2 billion of legal cannabis sales in Canada," said Raj Grover, Founder and Chief Executive Officer of High Tide.
"This level of sequential and year-over-year growth reinforces our conviction that Germany is only the beginning. We are building a repeatable, capital-efficient distribution engine that can be expanded across Europe, subject to regulatory conditions. We fully intend to leverage this momentum to continue taking share in Germany while methodically entering additional high-growth markets," added Mr. Grover.
Germany imported 201.1 tonnes of medical cannabis in 2025, more than doubling the previous year's 72.9 tonnes, with almost half of its imports (over 93 tonnes) coming from Canada.
For more information:
High Tide
[email protected]
hightideinc.com
